Global Binge Eating Disorder Drug Market Growth 2023-2029

Global Binge Eating Disorder Drug Market Growth 2023-2029

Binge eating disorder is a serious condition characterized by uncontrollable eating and resulting weight gain. The causes of binge-eating disorder are unknown. But family history, biological factors, long-term dieting and psychological issues increase risk. Signs and symptoms include eating unusually large amounts of food, frequently eating alone, feeling that eating behavior is out of control and experiencing depression and anxiety. Treatment includes psychOthersapy, medications and behavioral weight-loss programs.

LPI (LP Information)' newest research report, the “Binge Eating Disorder Drug Industry Forecast” looks at past sales and reviews total world Binge Eating Disorder Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Binge Eating Disorder Drug sales for 2023 through 2029. With Binge Eating Disorder Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Binge Eating Disorder Drug industry.

This Insight Report provides a comprehensive analysis of the global Binge Eating Disorder Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Binge Eating Disorder Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Binge Eating Disorder Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Binge Eating Disorder Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Binge Eating Disorder Drug.

The global Binge Eating Disorder Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Binge Eating Disorder Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Binge Eating Disorder Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Binge Eating Disorder Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Binge Eating Disorder Drug players cover Roche, Chronos Therapeutics, Heptares, Novo Nordisk, Omeros Corp, Sunovion Pharmaceuticals and Opiant Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Binge Eating Disorder Drug market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Antidepressants
Anticonvulsants
Anti-obesity Medications

Segmentation by application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Chronos Therapeutics
Heptares
Novo Nordisk
Omeros Corp
Sunovion Pharmaceuticals
Opiant Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Binge Eating Disorder Drug market?

What factors are driving Binge Eating Disorder Drug market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Binge Eating Disorder Drug market opportunities vary by end market size?

How does Binge Eating Disorder Drug break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.